nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—CYP1A2—Carmustine—melanoma	0.239	0.328	CbGbCtD
Moclobemide—CYP1A2—Vemurafenib—melanoma	0.189	0.259	CbGbCtD
Moclobemide—CYP2D6—Vemurafenib—melanoma	0.155	0.214	CbGbCtD
Moclobemide—CYP1A2—Dacarbazine—melanoma	0.145	0.199	CbGbCtD
Moclobemide—Procainamide—SCN11A—melanoma	0.00623	0.547	CrCbGaD
Moclobemide—Photopsia—Docetaxel—melanoma	0.00462	0.0283	CcSEcCtD
Moclobemide—Apathy—Temozolomide—melanoma	0.00309	0.0189	CcSEcCtD
Moclobemide—Flat affect—Temozolomide—melanoma	0.00307	0.0188	CcSEcCtD
Moclobemide—Aggression—Bleomycin—melanoma	0.00298	0.0183	CcSEcCtD
Moclobemide—Dry skin—Vemurafenib—melanoma	0.00288	0.0176	CcSEcCtD
Moclobemide—Procainamide—SCN10A—melanoma	0.00234	0.206	CrCbGaD
Moclobemide—Hepatic enzyme increased—Temozolomide—melanoma	0.00234	0.0143	CcSEcCtD
Moclobemide—Bezafibrate—PPARG—melanoma	0.00228	0.2	CrCbGaD
Moclobemide—Heartburn—Docetaxel—melanoma	0.00214	0.0131	CcSEcCtD
Moclobemide—Disorientation—Bleomycin—melanoma	0.00213	0.013	CcSEcCtD
Moclobemide—Dermatitis atopic—Docetaxel—melanoma	0.00199	0.0122	CcSEcCtD
Moclobemide—Dysgeusia—Vemurafenib—melanoma	0.00185	0.0113	CcSEcCtD
Moclobemide—Hot flush—Temozolomide—melanoma	0.00171	0.0105	CcSEcCtD
Moclobemide—Menopausal symptoms—Temozolomide—melanoma	0.0017	0.0104	CcSEcCtD
Moclobemide—Myalgia—Vemurafenib—melanoma	0.00161	0.00985	CcSEcCtD
Moclobemide—Dry skin—Temozolomide—melanoma	0.00147	0.009	CcSEcCtD
Moclobemide—Hypotension—Vemurafenib—melanoma	0.00144	0.00882	CcSEcCtD
Moclobemide—Stomatitis—Bleomycin—melanoma	0.00143	0.00874	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00141	0.0086	CcSEcCtD
Moclobemide—Abdominal distension—Temozolomide—melanoma	0.0014	0.00854	CcSEcCtD
Moclobemide—Decreased appetite—Vemurafenib—melanoma	0.00134	0.00821	CcSEcCtD
Moclobemide—Stomatitis—Dactinomycin—melanoma	0.00133	0.00816	CcSEcCtD
Moclobemide—Fatigue—Vemurafenib—melanoma	0.00133	0.00814	CcSEcCtD
Moclobemide—Constipation—Vemurafenib—melanoma	0.00132	0.00808	CcSEcCtD
Moclobemide—Dysuria—Temozolomide—melanoma	0.0013	0.00794	CcSEcCtD
Moclobemide—Stomatitis—Carmustine—melanoma	0.00125	0.00763	CcSEcCtD
Moclobemide—Flushing—Bleomycin—melanoma	0.00122	0.00747	CcSEcCtD
Moclobemide—Stomatitis—Temozolomide—melanoma	0.0012	0.00738	CcSEcCtD
Moclobemide—Hallucination—Carmustine—melanoma	0.00114	0.00699	CcSEcCtD
Moclobemide—Hot flush—Docetaxel—melanoma	0.00114	0.00698	CcSEcCtD
Moclobemide—Flushing—Dactinomycin—melanoma	0.00114	0.00697	CcSEcCtD
Moclobemide—Menopausal symptoms—Docetaxel—melanoma	0.00113	0.00692	CcSEcCtD
Moclobemide—Visual disturbance—Docetaxel—melanoma	0.00113	0.00689	CcSEcCtD
Moclobemide—Asthenia—Vemurafenib—melanoma	0.00111	0.00678	CcSEcCtD
Moclobemide—Visual impairment—Carmustine—melanoma	0.00111	0.00677	CcSEcCtD
Moclobemide—Hallucination—Temozolomide—melanoma	0.0011	0.00676	CcSEcCtD
Moclobemide—Pruritus—Vemurafenib—melanoma	0.00109	0.00668	CcSEcCtD
Moclobemide—Visual impairment—Temozolomide—melanoma	0.00107	0.00655	CcSEcCtD
Moclobemide—Flushing—Carmustine—melanoma	0.00107	0.00652	CcSEcCtD
Moclobemide—Ill-defined disorder—Bleomycin—melanoma	0.00106	0.0065	CcSEcCtD
Moclobemide—Diarrhoea—Vemurafenib—melanoma	0.00106	0.00646	CcSEcCtD
Moclobemide—Migraine—Docetaxel—melanoma	0.00105	0.00643	CcSEcCtD
Moclobemide—Tinnitus—Temozolomide—melanoma	0.00103	0.00633	CcSEcCtD
Moclobemide—Malaise—Bleomycin—melanoma	0.00103	0.00632	CcSEcCtD
Moclobemide—Flushing—Temozolomide—melanoma	0.00103	0.0063	CcSEcCtD
Moclobemide—Dizziness—Vemurafenib—melanoma	0.00102	0.00624	CcSEcCtD
Moclobemide—Ill-defined disorder—Dactinomycin—melanoma	0.000991	0.00607	CcSEcCtD
Moclobemide—Vomiting—Vemurafenib—melanoma	0.000981	0.006	CcSEcCtD
Moclobemide—Dry skin—Docetaxel—melanoma	0.000978	0.00599	CcSEcCtD
Moclobemide—Chest pain—Bleomycin—melanoma	0.000975	0.00597	CcSEcCtD
Moclobemide—Myalgia—Bleomycin—melanoma	0.000975	0.00597	CcSEcCtD
Moclobemide—Rash—Vemurafenib—melanoma	0.000973	0.00595	CcSEcCtD
Moclobemide—Dermatitis—Vemurafenib—melanoma	0.000972	0.00595	CcSEcCtD
Moclobemide—Headache—Vemurafenib—melanoma	0.000966	0.00592	CcSEcCtD
Moclobemide—Discomfort—Bleomycin—melanoma	0.000963	0.0059	CcSEcCtD
Moclobemide—Malaise—Dactinomycin—melanoma	0.000963	0.0059	CcSEcCtD
Moclobemide—Dysgeusia—Temozolomide—melanoma	0.000946	0.00579	CcSEcCtD
Moclobemide—Confusional state—Bleomycin—melanoma	0.000942	0.00577	CcSEcCtD
Moclobemide—Vision blurred—Carmustine—melanoma	0.000942	0.00577	CcSEcCtD
Moclobemide—Tremor—Carmustine—melanoma	0.000936	0.00573	CcSEcCtD
Moclobemide—Agitation—Carmustine—melanoma	0.000919	0.00562	CcSEcCtD
Moclobemide—Nausea—Vemurafenib—melanoma	0.000916	0.00561	CcSEcCtD
Moclobemide—Vision blurred—Temozolomide—melanoma	0.00091	0.00557	CcSEcCtD
Moclobemide—Myalgia—Dactinomycin—melanoma	0.000909	0.00557	CcSEcCtD
Moclobemide—Tremor—Temozolomide—melanoma	0.000905	0.00554	CcSEcCtD
Moclobemide—Discomfort—Dactinomycin—melanoma	0.000898	0.0055	CcSEcCtD
Moclobemide—Angina pectoris—Docetaxel—melanoma	0.000898	0.0055	CcSEcCtD
Moclobemide—Ill-defined disorder—Temozolomide—melanoma	0.000896	0.00549	CcSEcCtD
Moclobemide—Agitation—Temozolomide—melanoma	0.000888	0.00543	CcSEcCtD
Moclobemide—Hypotension—Bleomycin—melanoma	0.000873	0.00535	CcSEcCtD
Moclobemide—Malaise—Temozolomide—melanoma	0.000871	0.00533	CcSEcCtD
Moclobemide—Hypertension—Carmustine—melanoma	0.000863	0.00528	CcSEcCtD
Moclobemide—Palpitations—Temozolomide—melanoma	0.000854	0.00523	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Bleomycin—melanoma	0.000851	0.00521	CcSEcCtD
Moclobemide—Myalgia—Carmustine—melanoma	0.000851	0.00521	CcSEcCtD
Moclobemide—Chest pain—Carmustine—melanoma	0.000851	0.00521	CcSEcCtD
Moclobemide—Anxiety—Carmustine—melanoma	0.000848	0.00519	CcSEcCtD
Moclobemide—Paraesthesia—Bleomycin—melanoma	0.000839	0.00514	CcSEcCtD
Moclobemide—Hypertension—Temozolomide—melanoma	0.000834	0.00511	CcSEcCtD
Moclobemide—Dyspnoea—Bleomycin—melanoma	0.000833	0.0051	CcSEcCtD
Moclobemide—Confusional state—Carmustine—melanoma	0.000823	0.00504	CcSEcCtD
Moclobemide—Myalgia—Temozolomide—melanoma	0.000822	0.00503	CcSEcCtD
Moclobemide—Anxiety—Temozolomide—melanoma	0.00082	0.00502	CcSEcCtD
Moclobemide—Discomfort—Temozolomide—melanoma	0.000813	0.00497	CcSEcCtD
Moclobemide—Decreased appetite—Bleomycin—melanoma	0.000812	0.00497	CcSEcCtD
Moclobemide—Dry mouth—Temozolomide—melanoma	0.000804	0.00492	CcSEcCtD
Moclobemide—Stomatitis—Docetaxel—melanoma	0.000801	0.00491	CcSEcCtD
Moclobemide—Conjunctivitis—Docetaxel—melanoma	0.000799	0.00489	CcSEcCtD
Moclobemide—Tachycardia—Carmustine—melanoma	0.000796	0.00487	CcSEcCtD
Moclobemide—Confusional state—Temozolomide—melanoma	0.000795	0.00487	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000794	0.00486	CcSEcCtD
Moclobemide—Feeling abnormal—Bleomycin—melanoma	0.00077	0.00471	CcSEcCtD
Moclobemide—Hypotension—Carmustine—melanoma	0.000762	0.00467	CcSEcCtD
Moclobemide—Hyperhidrosis—Temozolomide—melanoma	0.000762	0.00467	CcSEcCtD
Moclobemide—Decreased appetite—Dactinomycin—melanoma	0.000758	0.00464	CcSEcCtD
Moclobemide—Fatigue—Dactinomycin—melanoma	0.000751	0.0046	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Carmustine—melanoma	0.000743	0.00455	CcSEcCtD
Moclobemide—Urticaria—Bleomycin—melanoma	0.000742	0.00455	CcSEcCtD
Moclobemide—Insomnia—Carmustine—melanoma	0.000738	0.00452	CcSEcCtD
Moclobemide—Paraesthesia—Carmustine—melanoma	0.000733	0.00448	CcSEcCtD
Moclobemide—Dyspnoea—Carmustine—melanoma	0.000727	0.00445	CcSEcCtD
Moclobemide—Somnolence—Carmustine—melanoma	0.000725	0.00444	CcSEcCtD
Moclobemide—Feeling abnormal—Dactinomycin—melanoma	0.000718	0.0044	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Temozolomide—melanoma	0.000718	0.0044	CcSEcCtD
Moclobemide—Insomnia—Temozolomide—melanoma	0.000713	0.00437	CcSEcCtD
Moclobemide—Gastrointestinal pain—Dactinomycin—melanoma	0.000713	0.00436	CcSEcCtD
Moclobemide—Visual impairment—Docetaxel—melanoma	0.000711	0.00435	CcSEcCtD
Moclobemide—Decreased appetite—Carmustine—melanoma	0.000709	0.00434	CcSEcCtD
Moclobemide—Paraesthesia—Temozolomide—melanoma	0.000708	0.00433	CcSEcCtD
Moclobemide—Dyspnoea—Temozolomide—melanoma	0.000703	0.0043	CcSEcCtD
Moclobemide—Somnolence—Temozolomide—melanoma	0.000701	0.00429	CcSEcCtD
Moclobemide—Constipation—Carmustine—melanoma	0.000698	0.00427	CcSEcCtD
Moclobemide—Dyspepsia—Temozolomide—melanoma	0.000694	0.00425	CcSEcCtD
Moclobemide—Abdominal pain—Dactinomycin—melanoma	0.000689	0.00422	CcSEcCtD
Moclobemide—Decreased appetite—Temozolomide—melanoma	0.000685	0.0042	CcSEcCtD
Moclobemide—Flushing—Docetaxel—melanoma	0.000685	0.00419	CcSEcCtD
Moclobemide—Fatigue—Temozolomide—melanoma	0.00068	0.00416	CcSEcCtD
Moclobemide—Constipation—Temozolomide—melanoma	0.000674	0.00413	CcSEcCtD
Moclobemide—Feeling abnormal—Carmustine—melanoma	0.000672	0.00412	CcSEcCtD
Moclobemide—Asthenia—Bleomycin—melanoma	0.000671	0.00411	CcSEcCtD
Moclobemide—Gastrointestinal pain—Carmustine—melanoma	0.000667	0.00408	CcSEcCtD
Moclobemide—Pruritus—Bleomycin—melanoma	0.000661	0.00405	CcSEcCtD
Moclobemide—Feeling abnormal—Temozolomide—melanoma	0.00065	0.00398	CcSEcCtD
Moclobemide—Abdominal pain—Carmustine—melanoma	0.000645	0.00395	CcSEcCtD
Moclobemide—Gastrointestinal pain—Temozolomide—melanoma	0.000645	0.00395	CcSEcCtD
Moclobemide—Dysgeusia—Docetaxel—melanoma	0.000629	0.00385	CcSEcCtD
Moclobemide—Urticaria—Temozolomide—melanoma	0.000626	0.00383	CcSEcCtD
Moclobemide—Asthenia—Dactinomycin—melanoma	0.000625	0.00383	CcSEcCtD
Moclobemide—Abdominal pain—Temozolomide—melanoma	0.000623	0.00382	CcSEcCtD
Moclobemide—Diarrhoea—Dactinomycin—melanoma	0.000596	0.00365	CcSEcCtD
Moclobemide—Vomiting—Bleomycin—melanoma	0.000594	0.00364	CcSEcCtD
Moclobemide—Rash—Bleomycin—melanoma	0.000589	0.00361	CcSEcCtD
Moclobemide—Dermatitis—Bleomycin—melanoma	0.000589	0.0036	CcSEcCtD
Moclobemide—Asthenia—Carmustine—melanoma	0.000585	0.00358	CcSEcCtD
Moclobemide—Syncope—Docetaxel—melanoma	0.000576	0.00353	CcSEcCtD
Moclobemide—Palpitations—Docetaxel—melanoma	0.000568	0.00348	CcSEcCtD
Moclobemide—Asthenia—Temozolomide—melanoma	0.000566	0.00346	CcSEcCtD
Moclobemide—Loss of consciousness—Docetaxel—melanoma	0.000565	0.00346	CcSEcCtD
Moclobemide—Diarrhoea—Carmustine—melanoma	0.000558	0.00342	CcSEcCtD
Moclobemide—Pruritus—Temozolomide—melanoma	0.000558	0.00341	CcSEcCtD
Moclobemide—Nausea—Bleomycin—melanoma	0.000555	0.0034	CcSEcCtD
Moclobemide—Hypertension—Docetaxel—melanoma	0.000555	0.0034	CcSEcCtD
Moclobemide—Vomiting—Dactinomycin—melanoma	0.000554	0.00339	CcSEcCtD
Moclobemide—Rash—Dactinomycin—melanoma	0.00055	0.00336	CcSEcCtD
Moclobemide—Chest pain—Docetaxel—melanoma	0.000547	0.00335	CcSEcCtD
Moclobemide—Myalgia—Docetaxel—melanoma	0.000547	0.00335	CcSEcCtD
Moclobemide—Dizziness—Carmustine—melanoma	0.000539	0.0033	CcSEcCtD
Moclobemide—Diarrhoea—Temozolomide—melanoma	0.000539	0.0033	CcSEcCtD
Moclobemide—Dry mouth—Docetaxel—melanoma	0.000535	0.00327	CcSEcCtD
Moclobemide—Haloperidol—ABCB1—melanoma	0.00053	0.0466	CrCbGaD
Moclobemide—Confusional state—Docetaxel—melanoma	0.000529	0.00324	CcSEcCtD
Moclobemide—Dizziness—Temozolomide—melanoma	0.000521	0.00319	CcSEcCtD
Moclobemide—Vomiting—Carmustine—melanoma	0.000519	0.00318	CcSEcCtD
Moclobemide—Nausea—Dactinomycin—melanoma	0.000518	0.00317	CcSEcCtD
Moclobemide—Shock—Docetaxel—melanoma	0.000516	0.00316	CcSEcCtD
Moclobemide—Rash—Carmustine—melanoma	0.000514	0.00315	CcSEcCtD
Moclobemide—Dermatitis—Carmustine—melanoma	0.000514	0.00315	CcSEcCtD
Moclobemide—Tachycardia—Docetaxel—melanoma	0.000512	0.00313	CcSEcCtD
Moclobemide—Headache—Carmustine—melanoma	0.000511	0.00313	CcSEcCtD
Moclobemide—Vomiting—Temozolomide—melanoma	0.000501	0.00307	CcSEcCtD
Moclobemide—Rash—Temozolomide—melanoma	0.000497	0.00304	CcSEcCtD
Moclobemide—Dermatitis—Temozolomide—melanoma	0.000497	0.00304	CcSEcCtD
Moclobemide—Headache—Temozolomide—melanoma	0.000494	0.00302	CcSEcCtD
Moclobemide—Hypotension—Docetaxel—melanoma	0.00049	0.003	CcSEcCtD
Moclobemide—Nausea—Carmustine—melanoma	0.000485	0.00297	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Docetaxel—melanoma	0.000478	0.00292	CcSEcCtD
Moclobemide—Insomnia—Docetaxel—melanoma	0.000474	0.0029	CcSEcCtD
Moclobemide—Paraesthesia—Docetaxel—melanoma	0.000471	0.00288	CcSEcCtD
Moclobemide—Nausea—Temozolomide—melanoma	0.000468	0.00287	CcSEcCtD
Moclobemide—Dyspnoea—Docetaxel—melanoma	0.000467	0.00286	CcSEcCtD
Moclobemide—Somnolence—Docetaxel—melanoma	0.000466	0.00285	CcSEcCtD
Moclobemide—Dyspepsia—Docetaxel—melanoma	0.000461	0.00283	CcSEcCtD
Moclobemide—Decreased appetite—Docetaxel—melanoma	0.000456	0.00279	CcSEcCtD
Moclobemide—Fatigue—Docetaxel—melanoma	0.000452	0.00277	CcSEcCtD
Moclobemide—Constipation—Docetaxel—melanoma	0.000448	0.00274	CcSEcCtD
Moclobemide—Feeling abnormal—Docetaxel—melanoma	0.000432	0.00264	CcSEcCtD
Moclobemide—Gastrointestinal pain—Docetaxel—melanoma	0.000429	0.00262	CcSEcCtD
Moclobemide—Abdominal pain—Docetaxel—melanoma	0.000414	0.00254	CcSEcCtD
Moclobemide—Asthenia—Docetaxel—melanoma	0.000376	0.0023	CcSEcCtD
Moclobemide—Pruritus—Docetaxel—melanoma	0.000371	0.00227	CcSEcCtD
Moclobemide—Diarrhoea—Docetaxel—melanoma	0.000359	0.0022	CcSEcCtD
Moclobemide—Dizziness—Docetaxel—melanoma	0.000347	0.00212	CcSEcCtD
Moclobemide—Vomiting—Docetaxel—melanoma	0.000333	0.00204	CcSEcCtD
Moclobemide—Rash—Docetaxel—melanoma	0.000331	0.00202	CcSEcCtD
Moclobemide—Dermatitis—Docetaxel—melanoma	0.00033	0.00202	CcSEcCtD
Moclobemide—Headache—Docetaxel—melanoma	0.000328	0.00201	CcSEcCtD
Moclobemide—Nausea—Docetaxel—melanoma	0.000311	0.00191	CcSEcCtD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CUBN—melanoma	8.65e-05	0.00088	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PHGDH—melanoma	8.45e-05	0.000861	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—LUM—melanoma	8.45e-05	0.000861	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—melanoma	8.35e-05	0.00085	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—HPSE—melanoma	8.29e-05	0.000844	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—melanoma	8.17e-05	0.000832	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—melanoma	8.17e-05	0.000832	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—melanoma	8.17e-05	0.000832	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CUBN—melanoma	8.13e-05	0.000828	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—GPAM—melanoma	8.09e-05	0.000824	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	8.07e-05	0.000822	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—TNF—melanoma	7.94e-05	0.000809	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CUBN—melanoma	7.88e-05	0.000803	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—SDHD—melanoma	7.86e-05	0.0008	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—BSG—melanoma	7.86e-05	0.0008	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CSPG4—melanoma	7.86e-05	0.0008	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CYP17A1—melanoma	7.81e-05	0.000796	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—melanoma	7.78e-05	0.000792	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—melanoma	7.78e-05	0.000792	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—melanoma	7.72e-05	0.000786	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—MDM2—melanoma	7.66e-05	0.00078	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ACER3—melanoma	7.62e-05	0.000775	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GPAM—melanoma	7.61e-05	0.000775	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—GNA11—melanoma	7.38e-05	0.000751	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—GPAM—melanoma	7.37e-05	0.000751	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—FASN—melanoma	7.22e-05	0.000735	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—SLC5A5—melanoma	7.1e-05	0.000723	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ACER3—melanoma	7e-05	0.000713	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—UGT2B10—melanoma	6.96e-05	0.000709	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ACER3—melanoma	6.94e-05	0.000707	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	6.88e-05	0.0007	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—GNAQ—melanoma	6.86e-05	0.000699	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CD44—melanoma	6.86e-05	0.000699	CbGpPWpGaD
Moclobemide—MAOA—Transmission across Chemical Synapses—MAPK1—melanoma	6.84e-05	0.000696	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CUBN—melanoma	6.74e-05	0.000686	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CYP1B1—melanoma	6.58e-05	0.00067	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—melanoma	6.56e-05	0.000668	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—HS3ST5—melanoma	6.47e-05	0.000659	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PLA2G6—melanoma	6.47e-05	0.000659	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—IL6—melanoma	6.41e-05	0.000652	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—UGT2B10—melanoma	6.41e-05	0.000652	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—UGT2B10—melanoma	6.35e-05	0.000647	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—GPAM—melanoma	6.3e-05	0.000642	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	6.27e-05	0.000639	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—HS3ST5—melanoma	5.96e-05	0.000606	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ACER3—melanoma	5.93e-05	0.000604	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—HS3ST5—melanoma	5.9e-05	0.000601	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—VCAN—melanoma	5.81e-05	0.000592	CbGpPWpGaD
Moclobemide—MAOA—Transmission across Chemical Synapses—HRAS—melanoma	5.49e-05	0.000559	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—UGT2B10—melanoma	5.43e-05	0.000553	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—ABCB1—melanoma	5.42e-05	0.000552	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	5.36e-05	0.000546	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—MAPK1—melanoma	5.24e-05	0.000533	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	5.21e-05	0.000531	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—HS3ST5—melanoma	5.05e-05	0.000514	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PRKCA—melanoma	4.98e-05	0.000508	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—ERCC2—melanoma	4.94e-05	0.000503	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PLCB4—melanoma	4.91e-05	0.0005	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CYP17A1—melanoma	4.9e-05	0.000499	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—FASN—melanoma	4.82e-05	0.00049	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	4.75e-05	0.000484	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GNA11—melanoma	4.63e-05	0.000472	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SLC6A11—melanoma	4.61e-05	0.00047	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIP4K2A—melanoma	4.61e-05	0.00047	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—FASN—melanoma	4.53e-05	0.000461	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PLCB4—melanoma	4.51e-05	0.00046	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—MTAP—melanoma	4.49e-05	0.000457	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PLCB4—melanoma	4.47e-05	0.000456	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—SLC5A5—melanoma	4.46e-05	0.000454	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	4.39e-05	0.000447	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	4.39e-05	0.000447	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CD44—melanoma	4.3e-05	0.000438	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GNAQ—melanoma	4.3e-05	0.000438	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIP4K2A—melanoma	4.24e-05	0.000432	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SLC6A11—melanoma	4.24e-05	0.000432	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIP4K2A—melanoma	4.21e-05	0.000428	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SLC6A11—melanoma	4.21e-05	0.000428	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—HRAS—melanoma	4.2e-05	0.000428	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—MTAP—melanoma	4.13e-05	0.00042	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CYP1B1—melanoma	4.13e-05	0.00042	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—MTAP—melanoma	4.09e-05	0.000417	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	4.06e-05	0.000414	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PHGDH—melanoma	4e-05	0.000407	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—LUM—melanoma	4e-05	0.000407	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	4e-05	0.000407	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—HPSE—melanoma	3.92e-05	0.000399	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PIK3CG—melanoma	3.9e-05	0.000398	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CUBN—melanoma	3.85e-05	0.000392	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PLCB4—melanoma	3.82e-05	0.000389	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PPARG—melanoma	3.77e-05	0.000384	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—FASN—melanoma	3.75e-05	0.000382	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—BSG—melanoma	3.72e-05	0.000379	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SDHD—melanoma	3.72e-05	0.000379	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CSPG4—melanoma	3.72e-05	0.000379	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PHGDH—melanoma	3.68e-05	0.000375	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—LUM—melanoma	3.68e-05	0.000375	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PHGDH—melanoma	3.65e-05	0.000371	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—LUM—melanoma	3.65e-05	0.000371	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—HPSE—melanoma	3.61e-05	0.000367	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GPAM—melanoma	3.6e-05	0.000367	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SLC6A11—melanoma	3.59e-05	0.000366	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIP4K2A—melanoma	3.59e-05	0.000366	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—HPSE—melanoma	3.58e-05	0.000364	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CUBN—melanoma	3.54e-05	0.000361	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CUBN—melanoma	3.51e-05	0.000358	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—MTAP—melanoma	3.5e-05	0.000356	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PIK3CD—melanoma	3.43e-05	0.00035	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CSPG4—melanoma	3.42e-05	0.000348	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—BSG—melanoma	3.42e-05	0.000348	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SDHD—melanoma	3.42e-05	0.000348	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	3.42e-05	0.000348	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ABCB1—melanoma	3.4e-05	0.000346	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SDHD—melanoma	3.39e-05	0.000345	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—BSG—melanoma	3.39e-05	0.000345	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CSPG4—melanoma	3.39e-05	0.000345	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—ALB—melanoma	3.39e-05	0.000345	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GPAM—melanoma	3.31e-05	0.000337	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GPAM—melanoma	3.28e-05	0.000334	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PRKCA—melanoma	3.13e-05	0.000319	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PHGDH—melanoma	3.12e-05	0.000317	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—LUM—melanoma	3.12e-05	0.000317	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ERCC2—melanoma	3.1e-05	0.000316	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PLA2G6—melanoma	3.06e-05	0.000312	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—HPSE—melanoma	3.06e-05	0.000311	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CUBN—melanoma	3e-05	0.000306	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PIK3CB—melanoma	2.99e-05	0.000305	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PTGS2—melanoma	2.96e-05	0.000302	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SDHD—melanoma	2.9e-05	0.000295	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CSPG4—melanoma	2.9e-05	0.000295	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—BSG—melanoma	2.9e-05	0.000295	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PLA2G6—melanoma	2.82e-05	0.000287	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GPAM—melanoma	2.81e-05	0.000286	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PLA2G6—melanoma	2.79e-05	0.000284	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—VCAN—melanoma	2.75e-05	0.00028	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.6e-05	0.000265	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PTEN—melanoma	2.59e-05	0.000263	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—VCAN—melanoma	2.53e-05	0.000258	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.51e-05	0.000256	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—VCAN—melanoma	2.51e-05	0.000255	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3CG—melanoma	2.45e-05	0.000249	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PLA2G6—melanoma	2.39e-05	0.000243	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.37e-05	0.000242	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PPARG—melanoma	2.36e-05	0.000241	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP17A1—melanoma	2.32e-05	0.000236	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.29e-05	0.000233	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.29e-05	0.000233	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	2.26e-05	0.00023	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GNA11—melanoma	2.19e-05	0.000223	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3CD—melanoma	2.15e-05	0.000219	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—FASN—melanoma	2.14e-05	0.000218	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—VCAN—melanoma	2.14e-05	0.000218	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP17A1—melanoma	2.13e-05	0.000217	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ALB—melanoma	2.13e-05	0.000217	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP17A1—melanoma	2.12e-05	0.000216	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SLC5A5—melanoma	2.11e-05	0.000215	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.09e-05	0.000213	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	2.06e-05	0.00021	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GNAQ—melanoma	2.04e-05	0.000208	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CD44—melanoma	2.04e-05	0.000208	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.03e-05	0.000207	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GNA11—melanoma	2.02e-05	0.000205	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GNA11—melanoma	2e-05	0.000204	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2e-05	0.000203	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.98e-05	0.000201	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—FASN—melanoma	1.97e-05	0.000201	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.96e-05	0.000199	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—FASN—melanoma	1.96e-05	0.000199	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP1B1—melanoma	1.95e-05	0.000199	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SLC5A5—melanoma	1.94e-05	0.000198	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SLC5A5—melanoma	1.92e-05	0.000196	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3CB—melanoma	1.88e-05	0.000191	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CD44—melanoma	1.87e-05	0.000191	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GNAQ—melanoma	1.87e-05	0.000191	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PTGS2—melanoma	1.86e-05	0.000189	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GNAQ—melanoma	1.86e-05	0.000189	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CD44—melanoma	1.86e-05	0.000189	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PIK3CA—melanoma	1.82e-05	0.000186	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.82e-05	0.000185	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP17A1—melanoma	1.81e-05	0.000184	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.8e-05	0.000184	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP1B1—melanoma	1.8e-05	0.000183	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.78e-05	0.000182	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP1B1—melanoma	1.78e-05	0.000181	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	1.76e-05	0.000179	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.72e-05	0.000176	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GNA11—melanoma	1.71e-05	0.000174	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—FASN—melanoma	1.67e-05	0.00017	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SLC5A5—melanoma	1.64e-05	0.000167	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PTEN—melanoma	1.62e-05	0.000165	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ABCB1—melanoma	1.61e-05	0.000164	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GNAQ—melanoma	1.59e-05	0.000162	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CD44—melanoma	1.59e-05	0.000162	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.57e-05	0.00016	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.55e-05	0.000158	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.54e-05	0.000157	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP1B1—melanoma	1.52e-05	0.000155	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—AKT1—melanoma	1.49e-05	0.000152	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PRKCA—melanoma	1.48e-05	0.000151	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ABCB1—melanoma	1.48e-05	0.000151	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ERCC2—melanoma	1.47e-05	0.00015	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ABCB1—melanoma	1.47e-05	0.000149	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PRKCA—melanoma	1.36e-05	0.000139	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ERCC2—melanoma	1.35e-05	0.000138	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PRKCA—melanoma	1.35e-05	0.000137	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.34e-05	0.000137	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ERCC2—melanoma	1.34e-05	0.000136	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ABCB1—melanoma	1.25e-05	0.000128	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.22e-05	0.000124	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3CG—melanoma	1.16e-05	0.000118	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PRKCA—melanoma	1.15e-05	0.000117	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3CA—melanoma	1.14e-05	0.000117	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ERCC2—melanoma	1.14e-05	0.000117	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PPARG—melanoma	1.12e-05	0.000114	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.11e-05	0.000113	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3CG—melanoma	1.07e-05	0.000109	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3CG—melanoma	1.06e-05	0.000108	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PPARG—melanoma	1.03e-05	0.000105	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PPARG—melanoma	1.02e-05	0.000104	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3CD—melanoma	1.02e-05	0.000104	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ALB—melanoma	1.01e-05	0.000102	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.48e-06	9.65e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3CD—melanoma	9.38e-06	9.55e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—AKT1—melanoma	9.35e-06	9.52e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3CD—melanoma	9.3e-06	9.47e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ALB—melanoma	9.26e-06	9.43e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ALB—melanoma	9.18e-06	9.34e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3CG—melanoma	9.04e-06	9.2e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3CB—melanoma	8.89e-06	9.05e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PTGS2—melanoma	8.8e-06	8.97e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PPARG—melanoma	8.72e-06	8.88e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3CB—melanoma	8.17e-06	8.32e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3CB—melanoma	8.1e-06	8.25e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PTGS2—melanoma	8.1e-06	8.25e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PTGS2—melanoma	8.03e-06	8.18e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3CD—melanoma	7.94e-06	8.09e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ALB—melanoma	7.84e-06	7.99e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PTEN—melanoma	7.68e-06	7.82e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PTEN—melanoma	7.06e-06	7.19e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PTEN—melanoma	7e-06	7.13e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3CB—melanoma	6.92e-06	7.05e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PTGS2—melanoma	6.86e-06	6.99e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PTEN—melanoma	5.98e-06	6.09e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3CA—melanoma	5.42e-06	5.52e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3CA—melanoma	4.98e-06	5.07e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3CA—melanoma	4.94e-06	5.03e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—AKT1—melanoma	4.43e-06	4.51e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3CA—melanoma	4.22e-06	4.3e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—AKT1—melanoma	4.07e-06	4.14e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—AKT1—melanoma	4.03e-06	4.11e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—AKT1—melanoma	3.45e-06	3.51e-05	CbGpPWpGaD
